Skip to content

Abdul Karim Arida, MD

NPI 1285205039ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· New Hartford, NY

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in New Hartford, New York, licensed in NY, with an NPI issued in July 2021. Part D covered 323 prescriptions written in 2024, 83% of them generic. Abbvie Inc. reported $15.88 in payments in 2025, mostly food and beverage.

Overview

NPI1285205039
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJul 2, 2021
Last updated in NPPESMay 14, 2026
Certified by providerMay 14, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (NY)

Part D prescriptions in 2024

Prescriptions (claims)323 · 716 30-day fills
Patients74
Total drug cost$74,079
Generic share83% of claims

Medicare sources and data years

Education and affiliations

Graduation year2018
Medicare specialtyEndocrinology

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$15.88 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Abbvie Inc.$15.881

What the 2025 payments were for

  • Food and Beverage$15.88 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in New Hartford

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in New York →